Market research
SQD.V SQI Diagnostics Inc
V CAD Healthcare
Latest close
As of 29 Dec 2024
Test a moving-average rule with historical data.
Market facts
- Market cap
- 6M
- P/E ratio
- Not available
- Analyst target
- 6
- Dividend yield
- Not available
- Beta
- -0.21
Profile
Instrument facts
- Exchange
- V
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- ISIN
- CA78466B1085
- Market cap
- 6M
- P/E ratio
- Not available
- Analyst target
- 6
- Dividend yield
- Not available
- Beta
- -0.21
About
About SQI Diagnostics Inc
SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow. The company was founded in 1999 and is headquartered in Toronto, Canada.
Research context
SQI Diagnostics Inc appears in PyInvesting’s TSX Venture Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Diagnostics & Research
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the SQD.V discussion.
5 years, 6 months ago
SQI Diagnostics Inc is currently in a long term downtrend where the price is trading 36.1% below its 200 day moving average.
From a valuation standpoint, the stock is 89.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 102.6.
SQI Diagnostics Inc's total revenue sank by 22.2% to $161K since the same quarter in the previous year.
Its net income has dropped by 84.6% to $-4M since the same quarter in the previous year.
Finally, its free cash flow grew by 27.4% to $-1M since the same quarter in the previous year.
Based on the above factors, SQI Diagnostics Inc gets an overall score of 2/5.